chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 5-10 minutes after immunization, patient reported feeling lightheaded, with ringing in her ears and tunnel-vision. Patient returned to the immunization booth and sat down for the next 20 minutes, with ice pack applied to back of neck and bottle of water to drink.  Patient did not lose consciousness, and lightheadedness resolved.
felt weak/dizzy, fainted , cant see well, couldnt walk or stand up , left side of body was numb
painful hypersensitivity skin reaction; redness / redness growing to about the size of a baseball; pain resembled a bad sunburn lasted one week; Pain in injection site; Itchy/itchiness resembled a bad sunburn; Rash moved (L) arm; Fatigue; Headache; Chills; Flu; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness / redness growing to about the size of a baseball), INFLUENZA (Flu), PAIN (pain resembled a bad sunburn lasted one week), HYPERSENSITIVITY (painful hypersensitivity skin reaction) and PRURITUS (Itchy/itchiness resembled a bad sunburn) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Paralysis (partial paralysis in both legs from traumatic injuries in 9/1995) in 1995. Concurrent medical conditions included Latex allergy (red extremely itchy rash). Concomitant products included FINASTERIDE from 11-May-2021 to an unknown date, PYRIDOXINE HYDROCHLORIDE (VITAMINE), VITAMIN D3 and BIFIDOBACTERIUM LACTIS (PROBIOTIC [BIFIDOBACTERIUM LACTIS]) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced INFLUENZA (Flu), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills). On 05-Feb-2021, the patient experienced PAIN (pain resembled a bad sunburn lasted one week), PRURITUS (Itchy/itchiness resembled a bad sunburn), RASH (Rash moved (L) arm) and VACCINATION SITE PAIN (Pain in injection site). On 06-Feb-2021, the patient experienced ERYTHEMA (redness / redness growing to about the size of a baseball). On an unknown date, the patient experienced HYPERSENSITIVITY (painful hypersensitivity skin reaction). The patient was treated with MULTIVITAMIN [VITAMINS NOS] ongoing since an unknown date at a dose of UNK, qd. On 12-Feb-2021, PAIN (pain resembled a bad sunburn lasted one week), PRURITUS (Itchy/itchiness resembled a bad sunburn), RASH (Rash moved (L) arm) and VACCINATION SITE PAIN (Pain in injection site) had resolved. At the time of the report, ERYTHEMA (redness / redness growing to about the size of a baseball), INFLUENZA (Flu), HYPERSENSITIVITY (painful hypersensitivity skin reaction), FATIGUE (Fatigue), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was reported as lotion.   This case was linked to MOD-2021-265895.   Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Updated Reporter Details. On 25-Jul-2021: Added other relevant history, added concomitant medications and added new events.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milligram. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Reporter states that because their facility has not been able to download the digital data logger, they have been put on hold by the State at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment by the State is made. There have been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility is unable to download the digital data logger, they will need to treat this issue as a temperature excursion. The data logger that caller is unable to download are for the months of DEC2021, JAN2022, and FEB2022. She says that they are filling out a temperature excursion assessment with the State at this time and she is calling in to report the same.  Patients have been administered doses while the temperature excursion assessment has been ongoing.  No adverse reactions were reported by any patients.  No treatment information were provided.    This case was linked to MOD-2022-501575 (Patient Link).
eye redness; Sore arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information reported.  Concomitant products included NAPROXEN SODIUM (ALEVE) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, OCULAR HYPERAEMIA (eye redness), MYALGIA (Sore arm) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Red itchy rash on left arm on and below my injection spot, slight bruise around injection spot
Parent called 1/30 to report fever was 102.5, reduced to 101.0 F after fever reducer given last evening. Pt still has fever today. No other symptoms at this time. Told parent to continue to monitor for 2-3 days, see doctor if worsens, not controlled by Tylenol beyond 2-3 days in case of viral infection instead of the common vaccine reaction.
persistant screaming episode; local rxn leg red, hot swollen; tx tempra, apply cool, wet compress;
6/17/02 received pneumovax 23 at hospital. On 6/18/02, patient's arm became painful and red with swelling from the site of injection to her elbow. As of 6/20/02, swelling, pain and redness no longer present - Left Arm.
Immediately following injection, patient slumped back and had brief twitching of limbs with transient loss of consciousness. For several minutes afterwards had some residual weakness left arm.
Soreness Extreme Fatigue Swelling Lymph nodes (left side only - neck, shoulder, armpit, breast) Headaches Pain on the upper left-hand side when deep breaths or sneezing Unable to sleep on left hand side
Fever; Feel off in general; This case was reported by a consumer via other manufacturer and described the occurrence of fever in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included dupilumab solution for injection in pre-filled pen for asthma.   On 21st October 2022, the patient received Shingrix. In February 2022, the patient started dupilumab (subcutaneous) 300 mg at an unknown frequency. In October 2022, less than a month after receiving Shingrix, the patient experienced fever and feeling abnormal. The action taken with dupilumab was unknown. On an unknown date, the outcome of the fever was recovering/resolving and the outcome of the feeling abnormal was not recovered/not resolved.   It was unknown if the reporter considered the fever and feeling abnormal to be related to Shingrix.     Additional Information: GSK Receipt Date: 28-Nov-2022 Reporter's Comments:  The patient developed pyrexia and feel of in general. The patient stated that this was not inaudible and feels better.    The additional information was received from patient via specialty pharmacy.
Patient received 2nd dose Pfizer (1st dose was Moderna). and also patient ended up receiving a 3rd dose with (outside provider).
In taking the oral typhoid medication, by the third pill pt felt weak, lethargic, dizzy, headache, queasy stomach and diarrhea.
On this date mom gives a hx of excessive sleeping, difficulty rousing & abn, dazed behavior 24 hrs p/1st DTP;
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. In approximately 2014 (reported as "1-2 years ago"), the patient was vaccinated with ZOSTAVAX injection (exact dose, lot #, expiration date and route of administration were not reported). In approximately 2014, 1 week after administration of ZOSTAVAX, the patient developed a rash at the injection site. The patient sought unspecified medical attention. The outcome of injection site rash was reported as recovered/resolved, on an unknown date. Causality assessment was not provided. Additional information is not expected, as the reporter refused additional contact.
10/4 around 11:30 am, had difficulty urinating at PCP's office to provide a UA sample. Drank maybe 5-8 oz of water. UA was concentrated with spec grav 1.025 but negative for UTI. Within 1-2 hours of PCP visit, had diarrhea and vomiting. Became confused and had a seizure at 8:30 pm. In a local Medical Center, found to have Na 125 and Cl 87, BUN 11, Creatinine 1.1. CT head, CXR, CT abd negative. Received NS and 3% to raise sodium. Discharged home 10/8.
OUT OF SPECIFICATION PRODUCT USE; INCORRECT PRODUCT STORAGE / VACCINE HAD BEEN LEFT OUT IN THE PHARMACY FOR GREATER THAN TWO HOURS PRIOR TO ADMINISTRATION; This spontaneous report received from a pharmacist concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced out of specification product use, and incorrect product storage / vaccine had been left out in the pharmacy for greater than two hours prior to administration. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the out of specification product use and incorrect product storage / vaccine had been left out in the pharmacy for greater than two hours prior to administration was not reported. This report was non-serious. This case, involving the same patient is linked to 20220548150.
Patient became dizzy and unconscious. She has a history of fear of needles and reported that she passed out before when receiving vaccines and doing blood work. She is pregnant at the time of the vaccinated.
2 pts vax w/ hepta B; devel h/a.  No tx given.  Resolved in both pts.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe
01/08/2007 patient received Pneumovax and developed fevers up to 104, body ache, injection site warmth, not red.
Patient felt lightheaded and out of it for about 10 minutes.  Was able to answer questions properly the entire time.  Patient did not fall or pass out.
Patient developed what appeared to be a shingle outbreak after receiving shingrix which consisted of a headache, rash in a dermatomal distribution (though not outright vesicles), and lymph node tenderness/enlargement.  It was similar to a shingles outbreak he had had in the past.  Patient received the Shingrix vaccine on Friday.  He developed a headache, joint aches and generally did not feel great.  3 days later he felt some discomfort in the back of his head.  He felt a bumpy sensation over the posterior top of his scalp.  This was not particularly tender but may be minimally itchy and felt generally "bumpy "  Also he felt an egg shaped tender lymph node-like feeling in his right posterior occipital area. He did have a history of shingles that that was on the left side of his head and it was associate with a left-sided headache and some red spots but no vesicles however developed.  This was many years ago.  He did see a physician assistant at his work who prescribed him on Valtrex.  The probable, tender lymph node on the right posterior scalp is definitely improving.  Its probably half the size it was yesterday.  He has no fever chills or sweats.  No vesicles.
CHIEF COMPLAINT COVID-19 pneumonia   HISTORY OF PRESENT ILLNESS Patient is a 75 y.o. male with medical comorbidities consisting atrial flutter on Eliquis, diabetes mellitus type 2 on oral agents, coronary artery disease, CIDP on CellCept and weekly IVIG infusions who presented to the emergency department with cough, shortness of breath and headache.  He has experienced these symptoms since 9/24/2021.  In the emergency department, COVID PCR returned positive.  Labs revealed INR 1.6, D-dimer 402, potassium 3.4.  Chest x-ray revealed vague patchy infiltrates in both lower lungs.  He was noted to have oxygen desaturations with activity.  He also had difficulty with ambulation.  He lives alone and is now being admitted to the Medicine 18 team for further management.   Upon my examination, he is lying in hospital bed.  Currently he has a strong frequent cough that is nonproductive.  He has also noted pretty persistent headache.  He has noted loss strength and weakness as well as loss of smell.  He notices his taste sensation has significantly changed.  He states he uses a walker at baseline but has been challenged over the past couple days with activity.  He states he has chronic dizziness with standing.  He has 3-4 loose bowel movements per day that has been happening for a few months.  He also has had some urinary urgency with urge incontinence for which he has urology appointment set.  He also endorses chronic numbness of the bottom of bilateral feet as well as finger tip "burning".  He denies chest pain, bleeding, skin wounds or rashes.
36 days after 2nd dose,  April 09, 2021, I experienced sweats and chills, weakness, delirium, loss of bowel control and an intense. 3 pain headache on the left forehead area. Realized a loss of sight in my left eye 11 days later.
pt c/o bones hurting approx 5min p/vax;cont to devel gen malaise into AM,  fever of 99.3 on Wednesday;fever inc to 102.5, not resolved w/APAP;gen rash red w/texture;by Thursday pt extremely weak, eyes sunken w/dark circles around them;
patient stated that Sunday she had back pain. Monday she walked to the car and was gasping for air. Friday she went to the hospital. Patient was having server adnominal pain and bloody stool. Patient was diagnosed with Keralites with bleeding, She has huge adnominal hernia, and her bowels are inflamed.
day of vaccine experienced body aches, cough, congestion, sore throat, clogged ears, subjective fevers and chills which resolved after 24 hours.   4/11 began with diffuse chest pain and left calf pain. shortness of breath
Difficulty breathing, paleness, weakness, fast heart beat, dizziness, low blood sugar, vomiting, nausea.  Had to be treated at hospital.
Woke up in the morning with vertigo, where I felt extremely dizzy.  This lasted a few days.  On the evening of the third day, the "world" would seem to tilt momentarily from my view.  From this day until treatment, symptoms were much more sever at night when laying down
This spontaneous report was received from a physician reffering to a patient of unknown age and gender. There was no information about the patient's concurrent conditions and medical history provided. On an unknown date, the patient was vaccinated with improperly stored dose of VARIVAX subcutaneously lot# R006753, expiration date 06-MAR-2020 or dose of VARIVAX subcutaneously lot # N026999, expiration date 28-SEP-2019 (also reported as 20-SEP-2019),  for prophylaxis. It was unspecified which lots of VARIVAX was given to the patient. The sterile diluent used to reconstitute the vaccine was properly stored. There was no adverse effect reported. Administered doses of vaccine were exposed to the temperature excursion of -14 degrees Celsius to -10 degrees Celsius (-13.7 degrees Celsius) for 2 hours 6 minutes. Data logger was involved. There were no previous temperature excursions. This is one of three reports received from the same reporter.; Sender's Comments: US-009507513-1808USA004633: US-009507513-1808USA004634:
pt recvd vax; exp cellulitis; devel inject site rxn consisting of swelling, erythema, hot to touch;
Nausea, vomiting, diaphoretic, pale within 2-3 minutes.
She got her 2nd Covid19 vaccine about a week ago in her right arm and her left arm hurt.; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received second dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in Arm Right on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. Patient had historical vaccine of first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date the patient experienced she got her 2nd covid19 vaccine about a week ago in her right arm and her left arm hurt. She got her 2nd Covid19 vaccine about a week ago in her right arm and her left arm hurts. And if you get her to the medical information, I tried to give her the phone number but she declined it. If you can transfer her over there to find out if that is from the Covid19 vaccine. Consumer hung up the call before it could be transferred to Pfizer Drug Safety. Call Back was done but it was unsuccessful. Hence, limited information available over the call. Thus, product  details (LOT#, NDC#, UPC# and expiry date) and pharmacy details could not be probed over the call. The outcome of event was unknown.  Information about lot/batch has been requested.
pt cried 1hr p/vax;fever, runny nose, crossed eyes 2-3hr p/vax;19MAR97 rash, confluent in diaper area, on trunk but not on face;seen by MD measles vax rxn;21MAR to MD wax in ear;23MAR to ER ear infect;rash secondary to measles;blue nails
Approximately 15 minutes after flu vaccination, she began experiencing nausea and then vomited.  She took Benadryl 50mg po.  She then over the next 20-30 minutes started itching and had hives to her chest and abdomen.  She then experienced chest tightness, persistent nausea and vomiting.
Approx 1 1/2 hours after injection, pt became dizzy, weak, had SOB and dry, swollen throat. This volunteer fireman did not report reaction until 3/24/03 when due for 2nd Hep B. To my knowledge he sought no medical care. He has not responded to 2 calls requesting more info.
Chills, fever, aches, large red lump at injection site all began about 18 hours after vaccine. Tylenol was taken for about 24 hours after the onset of reaction. Large red lump at injection site is still present 3 days later.
Ears ringing. It happened about 2-5 times for a short while over about 2 days either early this week or late last week. I did not associate it with the vaccine until reading an article about it today, so I just assumed it was the latest surprise from it aging body and didn't think to much of it. Also it head felt "hazy" at least once, but that has been happening literally my entire life.
achy; eyelid started twitching; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy), BLEPHAROSPASM (eyelid started twitching) and FATIGUE (tired) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (achy), BLEPHAROSPASM (eyelid started twitching) and FATIGUE (tired). On 20-Mar-2021, PAIN (achy) and FATIGUE (tired) had resolved. At the time of the report, BLEPHAROSPASM (eyelid started twitching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   There is no concomitant medication information provided. No treatment information provided.